These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
78 related articles for article (PubMed ID: 1684694)
21. Possible interaction between cholecystokinin and dopamine. Govoni S; Yang HY; Bosio A; Pasinetti G; Costa E Adv Biochem Psychopharmacol; 1982; 33():437-44. PubMed ID: 7124508 [No Abstract] [Full Text] [Related]
22. Characterization of dopamine receptors mediating inhibition of excitatory synaptic transmission in the rat hippocampal slice. Hsu KS J Neurophysiol; 1996 Sep; 76(3):1887-95. PubMed ID: 8890301 [TBL] [Abstract][Full Text] [Related]
23. In vivo and in vitro studies on the regulation of cholinergic neurotransmission in striatum, hippocampus and cortex of aged rats. Consolo S; Wang JX; Fiorentini F; Vezzani A; Ladinsky H Brain Res; 1986 May; 374(2):212-8. PubMed ID: 3013365 [TBL] [Abstract][Full Text] [Related]
24. Effect of aging on striatal dopamine receptor subtype recovery following N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline blockade and relation to motor function in Wistar rats. Henry JM; Joseph JA; Kochman K; Roth GS Brain Res; 1987 Aug; 418(2):334-42. PubMed ID: 2960421 [TBL] [Abstract][Full Text] [Related]
25. Behavioral and biochemical expression of D1-receptor supersensitivity following SCH 23390 repeated administrations. Gandolfi O; Roncada P; Dall'Olio R; Montanaro N Brain Res; 1988 Jul; 455(2):390-3. PubMed ID: 2969768 [TBL] [Abstract][Full Text] [Related]
26. Effects of lesions on somatostatin-like immunoreactivity in the rat striatum. Beal MF; Martin JB Brain Res; 1983 Apr; 266(1):67-73. PubMed ID: 6133592 [TBL] [Abstract][Full Text] [Related]
27. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation. Hu XT; White FJ Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677 [TBL] [Abstract][Full Text] [Related]
28. Studies of neurotensin-dopamine receptor interactions in striatal membranes of the male rat. The influence of 6-hydroxydopamine-induced dopamine receptor supersensitivity. Fuxe K; Agnati LF; Martire M; Neumeyer A; Benfenati F; Frey P Acta Physiol Scand; 1986 Jan; 126(1):147-9. PubMed ID: 3006432 [No Abstract] [Full Text] [Related]
29. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway. Sonsalla PK; Manzino L; Heikkila RE J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797 [TBL] [Abstract][Full Text] [Related]
30. Striatal ornithine decarboxylase activity following neurotoxic and mechanical lesions of the mesostriatal dopamine system of the male rat. Agnati LF; Fuxe K; Davalli P; Zini I; Corti A; Zoli M Acta Physiol Scand; 1985 Sep; 125(1):173-5. PubMed ID: 4050488 [No Abstract] [Full Text] [Related]
31. [The role of the adenyl cyclase system in cholinergic modulation of synaptic transmission in the hippocampus]. Goldukhin OV; Budantsev AIu; Shchipakina TG; Kondrat'ev VE Neirofiziologiia; 1989; 21(4):435-42. PubMed ID: 2572980 [TBL] [Abstract][Full Text] [Related]
32. Dopaminergic modulation of striatal neuropeptides: differential effects of D1 and D2 receptor stimulation on somatostatin, neuropeptide Y, neurotensin, dynorphin and enkephalin. Engber TM; Boldry RC; Kuo S; Chase TN Brain Res; 1992 May; 581(2):261-8. PubMed ID: 1356580 [TBL] [Abstract][Full Text] [Related]
33. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy. Calderon SF; Sanberg PR; Norman AB Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764 [TBL] [Abstract][Full Text] [Related]
34. Cholecystokinin release from the rat caudate-putamen, cortex and hippocampus is increased by activation of the D1 dopamine receptor. Brog JS; Beinfeld MC J Pharmacol Exp Ther; 1992 Jan; 260(1):343-8. PubMed ID: 1346163 [TBL] [Abstract][Full Text] [Related]
35. Dopaminergic grafts in the striatum reduce D1 but not D2 receptor-mediated rotation in 6-OHDA-lesioned rats. Robertson GS; Fine A; Robertson HA Brain Res; 1991 Jan; 539(2):304-11. PubMed ID: 1675908 [TBL] [Abstract][Full Text] [Related]
36. Evidence for a substrate of neuronal plasticity based on pre- and postsynaptic neurotensin-dopamine receptor interactions in the neostriatum. Fuxe K; O'Connor WT; Antonelli T; Osborne PG; Tanganelli S; Agnati LF; Ungerstedt U Proc Natl Acad Sci U S A; 1992 Jun; 89(12):5591-5. PubMed ID: 1535159 [TBL] [Abstract][Full Text] [Related]
37. Prenatal psychotropic drug exposure and the development of central dopaminergic and cholinergic neurotransmitter systems. Friedhoff AJ; Miller JC Monogr Neural Sci; 1983; 9():91-8. PubMed ID: 6310384 [No Abstract] [Full Text] [Related]
38. Restoration of nigrostriatal synaptic circuitry, striatal mRNA expression, and motor symmetry following embryonic substantia nigra grafts. Mendez I; Elisevich K; Naus C; Flumerfelt B Clin Neurosurg; 1992; 38():180-209. PubMed ID: 1371434 [No Abstract] [Full Text] [Related]
39. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems. Wachtel SR; Hu XT; Galloway MP; White FJ Synapse; 1989; 4(4):327-46. PubMed ID: 2532422 [TBL] [Abstract][Full Text] [Related]
40. Autoreceptor-mediated changes in dopaminergic terminal excitability: effects of striatal drug infusions. Tepper JM; Nakamura S; Young SJ; Groves PM Brain Res; 1984 Sep; 309(2):317-33. PubMed ID: 6089960 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]